Quick Answer
FATE THERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $46.63 million for the year ending 2025.
- FATE THERAPEUTICS INC showed an increase of +29.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), FATE THERAPEUTICS INC's Cash And Cash Equivalents At Carrying Value has grown by 315.4%.
- Historical annual values: Fiscal year 2025: $46.63 million | Fiscal year 2024: $36.06 million | Fiscal year 2023: $41.87 million | Fiscal year 2022: $61.33 million | Fiscal year 2021: $133.58 million | Fiscal year 2020: $167.35 million | Fiscal year 2019: $99.81 million | Fiscal year 2018: $190.51 million | Fiscal year 2017: $88.95 million | Fiscal year 2016: $88.61 million | Fiscal year 2015: $64.81 million | Fiscal year 2014: $49.10 million | Fiscal year 2013: $54.04 million | Fiscal year 2012: $9.09 million | Fiscal year 2011: $6.39 million | Fiscal year 2010: $11.23 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: